ZIF-8 and Its Magnetic Functionalization as Vehicle for the Transport and Release of Ciprofloxacin
Metadata
Show full item recordAuthor
Castillo Ramos, Ventura; García Reyes, Cinthia Berenice; Mangas García, Guillermo; Sampedro Quesada, María Inmaculada; Martínez-Checa Barrero, Fernando José; Sánchez Polo, ManuelEditorial
MDPI
Materia
Metal organic frameworks Magnetic ZIF-8 Drug release Ciprofloxacin Pharmaceutical
Date
2022-11-21Referencia bibliográfica
Ramos, V.C... [et al.]. ZIF-8 and Its Magnetic Functionalization as Vehicle for the Transport and Release of Ciprofloxacin. Pharmaceutics 2022, 14, 2546. [https://doi.org/10.3390/pharmaceutics14112546]
Sponsorship
P18-RT-4193Abstract
The use of nanomaterials for the controlled release of drugs aims to enhance their effectiveness,
especially when poorly soluble in water, and achieve their rapid, localized, and effective
administration. The present study focuses on the use of a Zeolitic Imidazolate Framework-8 (ZIF-8)
as vehicle for the transport and controlled release of the antibiotic ciprofloxacin (CIP) as model due to
its favorable physicochemical characteristics. The objective is to synthesize the ZIF-8 material loaded
with CIP through encapsulation for subsequent release of the drug in neutral and acid physiological
media. In addition, functionalization of the CIP/ZIF compound with magnetic nanoparticles (NP)
was sought to increase its traceability through the possible use of magnetic fields. Characterizations
by XRD, FT-IR, SEM-EDX, and TGA showed a satisfactory synthesis of both pure ZIF-8 and
ciprofloxacin-loaded ZIF-8, with high crystallinity and thermal stability. The release profiles showed
an abrupt initial release that stabilized over time. A much higher release (20–80% greater) was
obtained in acid versus neutral pH in all cases, attributable to the collapse of the ZIF-8 structure in
acid media. In addition, functionalization of the material with iron NPs did not affect the behavior
of the system during drug release. Antimicrobial activity tests against E. coli and S. aureus showed
that ZIF-8 per se exerts antimicrobial activity, while the compounds CIP/ZIF and magnetic CIP/ZIF
increased the antimicrobial capacity of pure CIP by 10–20%. The ZIF-8 system has high potential as a
drug carrier and release agent for the treatment of diseases, especially those that cause acidification
of the cellular environment, achieving a rapid, localized, and targeted action with the possibility of
achieving traceability of the system after its magnetic functionalization.